Previous Article | Next Article 
Molecular and Cellular Biology, April 2001, p. 2847-2857, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2847-2857.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
The Insert Region of Rac1 Is Essential for Membrane
Ruffling but Not Cellular Transformation
Antoine E.
Karnoub,1
Channing J.
Der,2,* and
Sharon L.
Campbell1
Department of Biochemistry and
Biophysics1 and Department of
Pharmacology,2 Lineberger Comprehensive Cancer
Center, University of North Carolina at Chapel Hill, Chapel Hill, North
Carolina 27599
Received 23 January 2001/Accepted 26 January 2001
 |
ABSTRACT |
The Rho family of Ras-related proteins, which includes Rac1, RhoA,
and Cdc42, is distinguished from other members of the Ras superfamily
of small GTPases in that its members possess additional sequences
positioned between
-strand 5 and
-helix 4, designated the insert
region. Previous studies have established the importance of an intact
insert region for the transforming, but not actin cytoskeletal
reorganization, activities of Cdc42 and RhoA. Similarly, the insert
region was determined to be essential for Rac1-mediated mitogenesis.
Additionally, an intact insert region was also determined to be
required for the antiapoptotic activity of Rac1 as well as for Rac1
activation of reactive oxygen species and the NF-
B transcription
factor. However, it has not been determined whether the insert region
is important for Rac1-mediated growth transformation. In this study, we
assessed the requirement for the insert region in Rac1 transformation
and signaling in NIH 3T3 cells. Unexpectedly, we found that a mutant of
constitutively activated Rac1 that lacked the insert region retained
potent transforming activity. The insert region of Rac1 was dispensable
for Rac1 stimulation of transcription from the cyclin D1 promoter and
for activation of the c-Jun, NF-
B, and E2F-1 transcription factors
but was essential for Rac1 induction of serum response factor activity.
While an intact insert region was dispensable for inducing reactive
oxygen species production in vivo, it was required for Rac1 induction
of lamellipodia. When taken together, these results show that the
insert region of Rac1 serves roles in regulating actin organization and
cell growth that are distinct from those of the analogous regions of
Cdc42 and RhoA and support its involvement in regulating specific
downstream effector interactions.
 |
INTRODUCTION |
Rac1 is a member of the Rho branch
of the Ras superfamily of small GTPases. To date, 15 mammalian Rho
family members have been identified, the best-characterized members
being Rac1, RhoA, and Cdc42 (61, 66). Rho family proteins
are binary switches that cycle between active GTP-bound and inactive
GDP-bound states to regulate actin cytoskeletal organization, gene
transcription, and cell growth. Their activity is positively regulated
by Dbl family guanine nucleotide exchange factors (GEFs) which catalyze the exchange of GDP for GTP to promote formation of the GTP-complex protein. Downregulation is achieved by GTPase-activating proteins, which enhance the intrinsic GTP hydrolysis rate, and guanine nucleotide dissociation inhibitors, which interfere with GTP hydrolysis and inhibit GDP-GTP exchange, favoring the formation of the GDP-bound protein.
Rac1 plays a key regulatory role in various cellular processes, such as
superoxide production, cell movement, proliferation, and apoptosis
(61). Rac1 also controls gene expression by regulating the
activity of transcription factors such as serum response factor (SRF)
(19), NF-
B (39), E2F-1 (17),
c-Jun, ATF-2, and Elk-1 (6). In addition, Rac1 promotes
the reorganization of filamentous actin into membrane structures called
lamellipodia or membrane ruffles, whereas RhoA and Cdc42 promote
stress fiber and filopodium formation, respectively (18).
Moreover, Rac1 is required for transformation induced by Ras
(29, 46) and other oncoproteins (e.g., Vav, Abl, and Mas)
(66). Finally, constitutive activation of Rac1 causes
anchorage-independent growth, invasion, and metastasis (9, 27,
36).
In light of the diverse functions of Rac1, it is not surprising that a
multitude of candidate effectors that bind preferentially to activated
Rac1-GTP have been identified (3, 61, 66). Rac1 effectors
include the PAK, MLK, and MEKK serine/threonine kinases, IQGAPs, POSH,
PORI, and Par-6 (47). Presently, no one specific protein
has been tied directly to the ability of Rac1 to transform cells and it
is likely that multiple effectors will be involved in Rac1 regulation
of cell proliferation.
An important approach for dissecting the contribution of specific
effectors and effector-mediated signaling pathways in Rac function has
been the analyses of mutants of Rac1 that are selectively impaired in a
subset of effector functions. A majority of these studies have utilized
missense mutations in the NH2-terminal effector domain
sequences of Rac1 that span residues 25 to 42 and include the core
effector domain (residues 32 to 40) and the switch I and switch II
domains, whose conformations are sensitive to the binding of GTP versus
GDP. However, studies involving Ras-RhoA, Rac1-Cdc42, and
Rac1-RhoA chimeras as well as missense mutations have identified
additional NH2- and COOH-terminal sequences that are
important for Rac1 effector interactions (14, 32, 51, 62).
Thus, multiple sequences of Rac1 are important for interaction with effectors.
Another region of Rac1 implicated in effector interaction has been the
surface-exposed and dynamic insert region (residues 124 to 135). Unlike
Ras and other members of the Ras superfamily, all Rho family GTPases
share a variable length short amino acid insertion between
-strand 5 and
-helix 4, designated the insert region (60).
Earlier studies initially determined that the insert region was
dispensable for Rac1 and Cdc42 activation of JNK and PAK1 and for actin
reorganization (24, 63). Mutants of Rac1 and Cdc42 lacking
the insert region were still responsive to regulation by
GTPase-activating proteins and GEFs and bound guanine nucleotides as
well as their wild-type counterparts did (59, 63).
However, recent reports indicated that the Rho family insert region is involved in effector interactions which are important for mediating cellular transformation. Mutation of the insert region was found to
abolish Cdc42- and RhoA-mediated transformation of NIH 3T3 cells
(64, 67). Similarly, deletion of the insert domain
impaired Rac1-induced DNA synthesis in REF-52 cells (24).
However, whether the insert region of Rac1 was also critical for
transformation was not determined.
Other functions of Rac1 have also been found to require an intact
insert domain. Rac1 increases the intracellular levels of reactive
oxygen species (ROS) in phagocytic cells (1, 10) as well
as nonphagocytic cells (28, 57, 58). Mutants of Rac1
lacking the insert region failed to activate the phagocytic NADPH
oxidase complex in vitro (13, 41) and to induce ROS production in REF-52 fibroblasts (24). One of the
best-characterized effects of ROS in cells is the activation of the
antiapoptotic NF-
B transcription factor (4, 56), and
deletion of the insert region was also found to abolish Rac1 activation
of NF-
B (24). Thus, the observation that the insert
region is also crucial for the antiapoptotic activity of Rac1 in REF-52
cells (25) may be due to the loss of the antiapoptotic
function of NF-
B.
In the present study, we have evaluated the importance of the insert
region in Rac1 transformation. Surprisingly, in contrast to what
has been observed for Cdc42 and RhoA (64, 67), we found
that deletion of the insert sequence did not abolish the transforming activity of the constitutively activated Rac1(61L) mutant when assessed in NIH 3T3 cells. Unexpectedly, in contrast to
previous observations in REF-52 cells, we also found that the insert
sequence was not essential for Rac1 production of ROS and activation of
NF-
B in NIH 3T3 cells. However, we observed that deletion of the
insert sequence perturbed the ability of Rac1 to activate SRF and to
promote the formation of membrane ruffles. Our observations suggest
that the insert region of Rac1 is functionally distinct from the insert
regions of RhoA and Cdc42 in regulating effector functions involved in
the regulation of cellular transformation and actin cytoskeletal organization.
 |
MATERIALS AND METHODS |
Molecular constructs.
Mammalian expression vectors encoding
the constitutively activated and transforming Rac1(61L) mutant
[pCGN-rac1(61L)] or the NH2-terminally
truncated and transforming Raf-22W mutant (pZIP-raf-22W) have been described and characterized previously (62).
Reporter plasmids in which luciferase gene expression is regulated by
minimal promoter sequences containing responsive elements for SRF,
NF-
B, and c-Jun or the human cyclin D1 promoter (pCD1-luc) have been described previously (2, 62). The E2F-1-responsive
luciferase reporter containing the luciferase gene under the control of
the human E2F-1 promoter was a kind gift from Peggy J. Farnham
(Madison, Wis.) and has been described and characterized previously
(21).
Rac1(61L) mutagenesis.
To assess the role of the insert
region in human Rac1 function, we generated mutant cDNA sequences that
encoded either single amino acid substitutions (at residues 124, 127, and 130; see Fig. 1) or a deletion of the entire insert region
(residues 124 to 135) of the constitutively activated Rac1(61L) mutant
protein. The human rac1(61L) cDNA sequence was subcloned
into the BamHI site of pBluescript SK+ (pBS SK+) and
mutagenized using the Chameleon kit (Stratagene). The mutagenic
oligonucleotides were generated in an Applied Biosystems synthesizer
and were 5' phosphorylated. The selection primer was used to change the
XhoI site of pBS SK+ to an NdeI site as described
by Westwick et al. (62). Sequences of the rac1
mutagenesis oligonucleotides were as follows: D124A, 5' CAG TTT
CTC GAT CGT TGC TTT ATC ATC CCT AAG 3'; E127A, 5' CTT CAG
TTT TGC GAT CGT GT 3'; and K130A, 5' CAG CTT CTT CTC TGC CAG TTT CTC G 3'. The insert deletion mutant, designated Rac1(61L,
ins), was designed identically to that described by Freeman et al.
(13), in which residues 124 to 135 were deleted and
proline 136 was replaced with an alanine, and was constructed as
follows. Two restriction enzymes, BanI and NcoI,
were used to digest the rac1(61L) cDNA at positions 305 and
431, respectively. The DNA stretch (base pairs 306 to 431) was replaced
by another DNA sequence (lacking base pairs coding for the insert
region) formed of two annealed oligonucleotide pairs, A1-C3 and B2-D4.
Sequences of the oligonucleotides were as follows, with restriction
sites for BanI and NcoI underlined: A1, 5'
GCA CCACTG TCC CAA CAC TCC CAT CAT CCT AGT GGG AAC TAA ACT
TGA 3'; B2, 5' TCT TAG GGA TGA TAA AGC AAT CAC CTA TCC GCA
GGG TCT AGC 3'; C3, 5' TTT ATC ATC CCT AAG ATC AAG TTT AGT
TCC CAC TAG GAT GAT GGG AGT GTT GGG ACA GTG 3'; and D4, 5'
CAT GGC TAG ACC CTG CGG ATA GGT GAT TGC 3'.
Introduction of the desired mutations in the rac1 cDNA
sequences was verified by automated sequencing.
Transient expression reporter analyses.
For transient
luciferase assays, NIH 3T3 cells were cotransfected with the
pCGN-rac1 expression constructs and pCD1-luc or the SRF-,
c-Jun-, NF-
B-, or E2F-1-responsive luciferase reporter plasmid using
the calcium phosphate precipitation method (5) and were
grown in Dulbecco's modified Eagle medium supplemented with 10% calf
serum for 48 h. Cultures were subsequently starved for 14 to
18 h in medium supplemented with 0.5% calf serum. The cells were
then lysed, and luciferase activity was measured using enhanced
chemiluminescence reagents (Amersham) in a Monolight 2010 luminometer
(Analytical Luminescence, San Diego, Calif.).
NIH 3T3 cell transformation assays.
The consequences of the
insert sequence mutations on Rac1(61L) transforming activity were
determined using two different assays. First, the ability of Rac1(61L)
mutants to cooperate with activated Raf-22W to cause synergistic
enhancement of focus-forming activity in NIH 3T3 cells was assayed as
described previously (62). Briefly, subconfluent cultures
of NIH 3T3 cells seeded in 60-mm-diameter tissue culture dishes were
cotransfected with 500 ng of pCGN-rac1(61L) plasmid DNA
together with either 50 ng of pZIP-raf-22W or empty pZIP-NeoSV(x)1 plasmid DNA. The cultures were replenished with fresh
growth medium on alternate days until foci of transformed cells were
detected 14 to 16 days later. Cells were fixed in methanol-acetic acid
(10% each) solution and stained with 0.4% crystal violet, and the
number of foci was quantitated under the microscope. Second, NIH 3T3
cells stably expressing each Rac1 protein were analyzed for the ability
to proliferate in an anchorage-independent environment in soft agar.
NIH 3T3 cells transfected with 500 ng of the various Rac1 mutant
constructs were selected in growth medium supplemented with hygromycin
(200 µg per ml) for 7 to 10 days. Multiple drug-resistant colonies
were then pooled together, and the level of exogenous Rac1 protein
expression in each cell population was determined by Western blot
analysis using antihemagglutinin (anti-HA) epitope antibody (BAbCO).
Single-cell suspensions (104 cells per 60-mm dish) of each
cell population were then plated in growth medium supplemented with
0.3% agar (5). The appearance of colonies of
proliferating cells was monitored for up to 18 days.
Measurement of cellular proliferation.
Rac1 stimulates cell
cycle progression, causing an increase in DNA synthesis and cellular
proliferation (43). To analyze the role of the insert
region in Rac1-induced proliferation, we assessed the ability of
Rac1(61L,
ins) to drive DNA synthesis in NIH 3T3 cells using a
colorimetric cell proliferation enzyme-linked immunosorbent assay
(Roche Molecular Biochemicals, Mannheim, Germany). Briefly, NIH 3T3
cells stably expressing Rac1(61L) or Rac1(61L,
ins) or the cognate
pCGN vector were cultured in 96-well plates at 30 × 103 cells/well and serum starved for 24 h in growth
medium supplemented with 0.5% calf serum. The culture medium was
subsequently replenished with growth medium supplemented with 0.5%
calf serum and with a 10 µM final concentration of the thymidine
analogue 5-bromo-2'-deoxyuridine (BrdU) for 28 h (labeling
medium). The labeling medium was then removed and cells were fixed
prior to DNA denaturation. Measurement of BrdU incorporation into DNA
was assessed photometrically in a Benchmark microplate reader (Bio-Rad)
at a 655-nm absorbance wavelength.
Measurement of ROS production.
Rac1 elevates cellular levels
of ROS in many cell types, including fibroblasts. To assess the
involvement of the insert region in Rac1-mediated ROS production, we
measured intracellular levels of ROS using the peroxide-sensitive and
fluorescent dye 2',7'-dichlorohydrofluorescein diacetate
(H2DCFDA; Molecular Probes, Eugene, Oreg.) (56,
58). NIH 3T3 cells stably expressing each Rac1(61L) protein or
an empty vector-transfected (control) cell population was plated at
equal density on glass coverslips and maintained in growth medium for 24 h. The complete medium was subsequently replaced by growth medium supplemented with 0.5% calf serum for 14 h. Coverslips were
then washed twice in Hank's buffered saline solution (HBSS; Gibco-BRL)
lacking phenol red and incubated in 10 µM fresh H2DCFDA (Molecular Probes) in Hank's buffered saline solution for 15 min at
room temperature (4, 58). Images were immediately
collected on a laser confocal microscope (Leica TCS-NT) using a long
pass of a 515-nm filter.
Immunofluorescence analyses.
The expression and localization
of the different Rac1 mutants were analyzed by fluorescence microscopy.
NIH 3T3 cells stably expressing Rac1 proteins were plated on glass
coverslips, maintained in growth medium for 6 h, and serum starved
(0.5%) for 14 to 18 h. The cells were then fixed in 3.6%
formaldehyde-phosphate-buffered saline solution, blocked in 3% bovine
serum albumin, and permeabilized by treatment with 0.1% Triton X-100.
Cultures were probed first with anti-HA monoclonal antibody (MAb)
(BAbCO) followed by rhodamine-conjugated anti-mouse immunoglobulin G
(Jackson ImmunoResearch Labs, West Grove, Pa.). Cytoskeletal actin
organization was analyzed by detecting F-actin distribution using
fluorescein isothiocyanate (FITC)-conjugated phalloidin (Jackson Labs).
Cells were photographed at a ×100 magnification using a Zeiss Axiophot
fluorescence microscope.
 |
RESULTS |
To evaluate the contribution of the Rho insert region to
Rac1 signaling and transformation, we introduced either missense or
deletion mutations into the insert region of the constitutively activated and transforming Rac1(61L) mutant (Fig.
1). First, we introduced single
amino acid substitutions (D124A, E127A, and K130A) at insert region
residues that are solvent accessible and may facilitate Rac1
interaction with other proteins (20). We introduced
alanine substitutions to minimize the perturbation of the helical
nature of the insert region. Second, we also created a more extensive
mutation by the deletion of residues 124 to 135 and the conversion of
proline 136 to alanine. The resulting mutant was designated Rac1(61L,
ins) and is identical to the one utilized in previous studies using
the constitutively activated Rac1(12V) protein (13, 24,
25).

View larger version (24K):
[in this window]
[in a new window]
|
FIG. 1.
Mutation of the Rac1 insert region. (A) Alignment of the
insert sequences of RhoA, Rac1, and Cdc42 with that of H-Ras. (B)
Sequences of the Rac1 mutants showing altered residues in bold and
underlined. The Rac1(61L, ins) mutant lacks amino acids 124 to 135, with proline 136 mutated to alanine.
|
|
The insert region is not required for Rac1 transforming
activity.
Previous studies established the importance of an intact
insert region for Cdc42 and RhoA transforming activities in NIH 3T3 cells (64, 67). Similarly, an intact insert region was
also found to be required for Rac1-stimulated mitogenesis in transient expression analyses in REF-52 cells (24). However, whether
the insert is important for Rac1 transformation has not been
determined. To address this question, we have assessed the contribution
of this region to Rac1-mediated transformation of NIH 3T3 cells using focus formation and soft agar analyses. We and others have shown previously that Rac1 cooperates with activated Raf in focus formation transformation assays (29, 46). As shown in Fig.
2, cultures transfected with plasmids
encoding either activated Rac1(61L) or activated Raf-22W alone caused
little or no focus-forming activity. However, cotransfection of both
plasmids caused a synergistic focus-forming activity of over 80 foci per dish. Surprisingly, the insert point mutants as well as the
deletion mutant of Rac1(61L) all retained strong cooperative
focus-forming activity when coexpressed with Raf-22W. Interestingly, we
found that Rac1(61L,
ins) showed a reproducible ~20% greater
focus formation activity than nonmutated Rac1(61L). Additionally,
Rac1(61L,
ins)-induced foci were detectable at an earlier time (8 days after transfection) and generally progressed to larger sizes than
those caused by Rac1(61L). Thus, the deletion of the insert region
caused a modest but reproducibly observed increase rather than a
decrease in Rac1(61L) transforming activity.


View larger version (111K):
[in this window]
[in a new window]
|
FIG. 2.
Mutations in the Rho insert region do not impair the
ability of Rac1 to cooperate with Raf-22W in causing transformation in
NIH 3T3 cells. (A) Focus formation assay. NIH 3T3 cells were
cotransfected with 50 ng of pZIP-NeoSV(x)1 plasmid, together with 500 ng of pCGN-rac1 or empty pCGN-hygro. These groups
reproducibly generate low focus counts and were used to control for
background transformation. As indicated, cells were transfected with 50 ng of pZIP-raf(22W) along with the empty pCGN-hygro vector
or pCGN-hygro encoding Rac1(61L) or the insert mutants. Cultures were
fixed and stained in 0.4% crystal violet 14 to 16 days later. Data
shown are representative of at least three experiments performed
in duplicate for each mutant. (B) Quantitation of the number of foci
per dish. Colonies were counted using phase-contrast microscopy.
Results represent the means ± the standard errors of duplicate
samples in at least three experiments.
|
|
Next, we determined if an intact insert region was also dispensable for
Rac1(61L) induction of anchorage-independent growth
when cells are
suspended in soft agar. For these analyses, mass
populations of NIH 3T3
cells were stably transfected with the
empty pCGN-hygro expression
plasmid (vector) or pCGN-hygro plasmid
constructs encoding nonmutated
or insert region-mutated versions
of Rac1(61L). Western blot analyses
showed that the established
cell lines had comparable steady-state
levels of expression of
Rac1(61L) and each insert region mutant
protein, indicating that
the mutations did not cause a significant
change in protein stability
(Fig.
3).
Whereas empty vector-transfected NIH 3T3 cells did not
form colonies
when suspended in soft agar (Fig.
4),
cells stably
expressing the Rac1(61L) protein were able to proliferate
under
anchorage-independent conditions. Again, the insert mutants
retained
their transforming potential, with robust formation of
multicellular
colonies after 18 days in culture. It is noteworthy that,
similar
to what was seen with the focus formation assays, Rac1(61L,

ins)-expressing
cells displayed an enhanced colony-forming activity
with a higher
frequency and an earlier onset of colony formation.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 3.
Mutations of the Rho insert region do not perturb
protein stability. Hygromycin-selected NIH 3T3 cells stably expressing
HA epitope-tagged Rac1(61L) or the indicated insert mutant protein were
lysed. The levels of Rac1 proteins expressed in each lysate were
determined by Western blotting using anti-HA MAbs (BAbCO). Comparable
levels of expression were detected in stable transfections of NIH 3T3
cells or in transient overexpression analyses in COS-7 cells (data not
shown).
|
|

View larger version (149K):
[in this window]
[in a new window]
|
FIG. 4.
The insert is not involved in Rac1-mediated
anchorage-independent growth of NIH 3T3 cells in soft agar. Pooled
populations of NIH 3T3 cells stably transfected with the empty
pCGN-hygro vector or vector encoding the indicated Rac1 mutant were
assayed for the ability to grow under anchorage-independent conditions.
Cells (2 × 104) of the indicated groups were seeded
into growth medium supplemented with 0.3% agar, and colonies were
photographed 18 days later under ×40 magnification. Results are
representative of two independent experiments performed in
triplicates.
|
|
Furthermore, we assessed the role of the insert region in Rac1-induced
cell cycle progression by measuring the ability of
Rac1(61L) and
Rac1(61L,

ins) to promote mitogenesis in NIH 3T3
cells (Fig.
5). Pooled populations of unsynchronized
serum-starved
cells stably expressing empty vector, Rac1(61L), or
Rac1(61L,

ins) were incubated in the presence of the thymidine
analogue
BrdU. Progression of cells through the S phase of the cell
cycle
was probed by quantitating the incorporation of BrdU into DNA.
As
shown in Fig.
5, Rac1(61L) caused about a 50% increase in BrdU
incorporation relative to the levels seen in vector-expressing
cells.
Surprisingly, deletion of the insert region did not inhibit
the
mitogenic ability of Rac1 in NIH 3T3 cells, as Rac1(61L,

ins)
caused
an increase in BrdU incorporation (1.87-fold) to levels
that
reproducibly exceeded those seen with Rac1(61L)-expressing
cells. Taken
together, these data exclude the involvement of the
insert region of
Rac1 in growth and transformation and contrast
with the critical role
of the insert sequences in mediating Cdc42
and RhoA transforming
activity when assessed in NIH 3T3 cells.

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 5.
The insert is not required for Rac1-induced DNA
synthesis in NIH 3T3 fibroblasts. DNA synthesis was assessed in pooled
populations of asynchronous NIH 3T3 cells stably transfected with empty
pCGN-hygro vector or expressing the indicated Rac1 mutant.
Serum-starved cells were incubated with a 10 µM final concentration
of the thymidine analogue BrdU. Measurement of BrdU incorporation into
DNA was assessed photometrically at a 655-nm absorbance wavelength.
Data are expressed as relative DNA synthesis over that obtained with
empty vector cells. Results are means ± standard errors of four
independent experiments performed in octuplets for each indicated
group.
|
|
An intact insert region is required for Rac1 induction of SRF but
not for cyclin D1 promoter-, c-Jun-, or E2F-1-mediated
transcription.
The growth promoting activity of Rac1 may be
mediated in part by regulating gene expression or cell cycle
progression. Therefore, we assessed whether the insert region was
involved in Rac1 activation of transcription factors that regulate the
expression of growth factor-responsive genes (SRF and Jun) or the
function of components important in the regulation of the
G1 phase of the cell cycle (cyclin D1 and E2F-1). For these
analyses, we performed transient expression reporter assays in NIH 3T3
cells utilizing reporter plasmids in which expression of the luciferase
gene was under the control of the human cyclin D1 promoter or minimal
promoters containing c-Jun-, E2F-1-, or SRF-responsive DNA elements.
First, we evaluated the involvement of the insert region in Rac1
activation of SRF. Rho family GTPases trigger signaling pathways
that
lead to the activation of SRF-dependent gene transcription
(
19). SRF activation has been shown previously to require
the
intact NH
2-terminal effector regions of Rac1 and RhoA
(
49,
62,
65). While the point mutants caused activation
comparable to
that seen with Rac1(61L) (20-fold), the deletion mutant
showed
a near-complete loss in its ability to stimulate SRF (80%
reduction)
(Fig.
6A). Thus, an intact
insert region, as well as the core
effector domain, is important in
mediating Rac1 stimulation of
SRF activity.

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 6.
The insert region is required for Rac1 activation of
SRF, but not cyclin D1, c-Jun, or E2F-1, in NIH 3T3 cells. Cells were
transiently transfected with 1.5 µg of luciferase reporter constructs
encoding promoter elements for SRF (A), c-Jun (B), cyclin D1 (C), or
E2F-1 (D), along with 1 µg of cognate pCGN vector or the indicated
Rac1 mutants using the calcium phosphate precipitation method.
Forty-eight hours later, cells were starved in medium supplemented with
0.5% calf serum for another 14 to 18 h and then lysed. Cell
extracts were analyzed using enhanced chemiluminescence reagents
(Amersham). Results are expressed as percent activation relative to
that observed with Rac1(61L). Average luciferase activity above that of
the vector control seen with Rac1(61L) was 28.6-fold for SRF, 5-fold
for cyclin D1, 6.7-fold for c-Jun, and 6.67-fold for E2F-1. Data shown
represent means ± standard errors of at least three independent
experiments performed in duplicate for each group. All proteins were
expressed to similar levels (data not shown).
|
|
Rac1 is an activator of the JNK mitogen-activated protein kinase
pathway. Activated JNK causes phosphorylation and activation
of the
c-Jun transcription factor, which is a component of the
AP-1
transcription factor and a key regulator of early response
and
growth-promoting genes (
6,
8,
37). We determined
previously
that Rac1 regulates SRF and Jun activation via distinct
effector
pathways (
62). Therefore, we determined if an
intact insert
region was required for Rac1 activation of c-Jun.
Transient expression
of Rac1(61L) caused a sixfold stimulation of
transcription from
a c-Jun-responsive luciferase promoter plasmid (Fig.
6B). Comparable
stimulation was seen with the missense or deletion
mutants of
Rac1(61L), indicating that the insert region is dispensable
for
Rac1 activation of the JNK-c-Jun
pathway.
Rac1 has a crucial function in the transition of cells through the
G
1 phase of the cell cycle and is needed for Ras- and
growth
factor-induced DNA synthesis (
43). Furthermore,
both Ras and
Rac control cell cycle progression, in part by stimulating
cyclin
D1 expression (
2,
62). We therefore tested whether
mutations
in the insert region affected the ability of Rac1(61L) to
stimulate
transcription from the cyclin D1 promoter. We found that the
point
mutants as well as the deletion mutant stimulated transcription
from the cyclin D1 promoter to levels that were comparable to
that seen
with their nonmutated counterpart (Fig.
6C). These results
indicate
that Rac1-mediated cyclin D1 activation does not require
the
insert
region.
Rac1 may alter cell cycle progression by activation of E2F
transcription factors, which in turn stimulate the expression of
genes
important for transition through the G
1 phase of the cell
cycle (
17). To address the importance of the insert region
in
Rac1 regulation of E2F-1-responsive gene expression, we performed
transient expression analyses in NIH 3T3 cells using a reporter
plasmid
in which the luciferase gene was regulated by E2F-1-responsive
promoter
elements. Rac1(61L), Rac1(61L, 124A), and Rac1(61L,

ins)
caused a
ninefold induction in luciferase activity (Fig.
6D).
The Rac1(61L,
127A) and Rac1(61L, 130A) insert mutants showed
limited (20 to
30%) reductions in stimulation. However, since
the deletion
mutant showed no reduction in activity, we concluded
that the
insert of Rac1 is not critical for Rac1 activation of
E2F-1-dependent
gene expression and that the enhanced transforming
potency of Rac1(61L,

ins) did not correlate with an enhanced
ability to activate these
signaling
pathways.
An intact insert region is dispensable for Rac1 activation of
NF-
B-mediated transcription and production of ROS.
Rho family
proteins and their GEFs promote NF-
B translocation to the nucleus
with subsequent stimulation of NF-
B-mediated transcriptional
activation (39, 44, 56). Previous microinjection analyses
showed that deletion of the insert region impaired the ability of
Rac1(61L) to activate NF-
B in REF-52 rat fibroblast cells
(25). Therefore, we evaluated whether the point mutations or the deletion also impaired the ability of Rac1(61L) to stimulate NF-
B-dependent transcription in NIH 3T3 cells. As shown in Fig. 7, Rac1(61L) caused a fivefold
enhancement of NF-
B-dependent transcription in transiently
transfected NIH 3T3 cells. Surprisingly, all the mutants of the insert
region retained strong abilities to stimulate transcription. In
particular, Rac1(61L,
ins) showed an enhanced (~50%) ability to
stimulate NF-
B-mediated transcription. These results show clearly
that the insert region of Rac1 is not required for NF-
B
transcriptional upregulation.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 7.
The insert region is dispensable for Rac1 activation of
NF- B-dependent transcriptional activation in NIH 3T3 cells.
Cells were cotransfected with 1.5 µg of NF- B luciferase
reporter plasmid and 1 µg of the indicated Rac1 mutant or vector
control. Results were analyzed and expressed as for Fig. 5. Data
shown represent the averages of three independent assays performed in
duplicates (± standard errors).
|
|
Previous studies indicated that Rac1 superoxide production is linked to
Rac1 activation of NF-

B (
4,
56). Furthermore,
the
insert region was found to be required for Rac1 stimulation
of
superoxide production when assayed by microinjection analyses
in COS-1
cells (
24). Since we found that the insert region was
not
required for NF-

B activation, we determined whether our
mutants
retained the ability to stimulate ROS production. To this end,
we have used the peroxide-sensitive marker DCFDA to compare the
levels
of ROS production in NIH 3T3 cells stably expressing Rac1(61L,

ins)
versus those expressing Rac1(61L). This compound has been
used
successfully to detect growth factor-, Ras-, and Rac1-dependent
upregulation of ROS levels in NIH 3T3 cells (
58) as well
as
other cell types (
33,
42,
53,
56,
57). NIH 3T3 cells
stably expressing Rac1(61L) exhibited a four- to fivefold enhancement
in their ROS levels above those seen in the empty vector-transfected
control cells (Fig.
8).
Surprisingly, we found that cells stably
expressing Rac1(61L,

ins) displayed a twofold higher ROS content
relative to that of
Rac1(61L)-expressing cells. The increased
ROS production was
not due to nonspecific protein expression,
as
Rac1(N17)-expressing cells exhibited no increase in DCFDA
fluorescence
(data not shown). Thus, consistent with our NF-

B
observation,
we found that the insert region of Rac1 is also not
required for
Rac1-induced production of ROS in NIH 3T3 cells.

View larger version (69K):
[in this window]
[in a new window]
|
FIG. 8.
Deletion of the insert region potentiates Rac1-induced
production of ROS. NIH 3T3 cells stably transfected with the empty
pCGN-hygro vector or pCGN-hygro encoding Rac(61L) or Rac1(61L, ins)
were plated on glass coverslips and starved for 14 h. Cells were
then washed and incubated in 10 µM DCFDA dye for 15 min at room
temperature. Slides were scanned immediately by laser confocal
microscopy using a >515-nm filter. Results shown are representatives
of three independent experiments.
|
|
An intact insert region is required for Rac1-induced membrane
ruffling.
Rac1 activation stimulates the reorganization of
cytoskeletal actin, leading to the formation of lamellipodia and
membrane ruffles (48). We therefore determined if mutation
or deletion of the insert region disrupted the ability of Rac1 to cause
membrane ruffling in NIH 3T3 cells. For these studies, NIH 3T3 cells
stably expressing Rac1(61L) or Rac1(61L,
ins) were fixed and probed with anti-HA epitope antibody coupled to rhodamine to detect HA-Rac1 expression and with FITC-conjugated phalloidin to visualize F-actin. Expression of Rac1(61L) (Fig. 9C) disrupted basal stress fiber formation (Fig. 9B) and caused a
redistribution of actin to membrane structures, forming lamellipodia or
membrane ruffles (Fig. 9D). Expression of the Rac1(61L,
ins) mutant
(Fig. 9E) induced relocalization of actin from stress fibers to the
cell membrane, but no membrane ruffling activity was detected (Fig.
9F). Interestingly, Rac1(61L,
ins)-expressing cells displayed
actin-rich microspikes at the plasma membrane, an activity more
characteristically associated with the activation of Cdc42. This
phenotype was independent of any secondary genetic alterations that may
have occurred during cell passage, since we observed similar results
when the analyses were done on transiently transfected NIH 3T3 cells
(data not shown). Moreover, the same phenotype was seen using
independently generated clones of the rac1(61L,
ins)
cDNA. These findings suggest that the insert of Rac1 is required for
membrane ruffling activity and that deletion of this region may cause
Rac1 to promote actin reorganization changes similar to those caused by
activated Cdc42. These results contrast with those seen with Cdc42 and
RhoA, where deletion of their insert regions did not perturb their
ability to promote filopodia and stress fibers, respectively (64,
67).

View larger version (66K):
[in this window]
[in a new window]
|
FIG. 9.
The insert region controls Rac1 membrane ruffling
activity in NIH 3T3 cells. NIH 3T3 stable cell lines of the indicated
groups were plated on coverslips, starved, fixed in 3.6%
formaldehyde-phosphate-buffered saline solution, and permeabilized
with 3% bovine serum albumin-0.1% Triton X-100-phosphate-buffered
saline solution. Exogenously expressed HA-tagged Rac1(61L) or Rac1(61L,
ins) protein was probed with anti-HA epitope MAbs (BAbCO; 1:500
dilution). F-actin distribution was detected with FITC-conjugated
phalloidin (Jackson Labs; 1:1,000 dilution). Immunostaining was
captured with a Leica Axiophot fluorescent microscope, and photographs
were taken with a ×100 oil lens. Results are representative of at
least five independently generated cell lines of each group. Results
were similar using two independently generated clones of the Rac1(61L,
ins) mutant. The same observations were seen in analyses of
transiently transfected NIH 3T3 cells (data not shown). *,
lamellipodia; >, filopodium-like extensions.
|
|
 |
DISCUSSION |
Members of the Rho family of GTPases share an additional amino
acid sequence, termed the Rho insert region, which distinguishes them
from all other members of the Ras superfamily. Recent mutational analyses showed that an intact Rho insert was required for the transforming, but not actin reorganization, activities of Cdc42 and
RhoA in NIH 3T3 cells (64, 67). In the present study, we
assessed the importance of the insert region in Rac1 signaling and
transforming activities. Surprisingly, we found that Rac1 transformation of NIH 3T3 cells did not require the insert region. However, we did find that deletion of this region impaired Rac1 activation of SRF and induction of membrane ruffling. Our results emphasize the distinct functional role of the insert region in Rac1
when compared to that of Cdc42 and RhoA.
Our observation that deletion of the insert region did not abolish Rac1
mitogenic and transforming activities contrasts with previous
observations that the same deletion caused impairment of the mitogenic
function of Rac1 (24). Several differences between the two
studies may account for the different conclusions. First, although the
same deletion was utilized in both studies, our mutation was introduced
into the Rac1(61L) mutant instead of the Rac1(12V) variant utilized by
Bar-Sagi and colleagues (24, 25). Although both are
constitutively activated and transforming mutants of Rac1, there is
evidence that they differ in their affinity for effector binding
(32). Hence, it is possible that the insert deletion
caused differential impairment of effector interactions in the G12V and
the Q61L mutant versions of Rac1. Second, whereas the previous study
evaluated the ability of transiently expressed protein to induce DNA
synthesis in REF-52 rat fibroblasts, our analyses determined the
consequences of sustained Rac1 activation in NIH 3T3 mouse fibroblasts.
Support for the potential importance of these differences has been
observed in related studies with Ras. Although transient expression of
activated Ras is mitogenic in REF-52 cells, sustained Ras activation
causes cell cycle arrest and senescence in these cells
(52). In contrast, transient or sustained activation of
Ras causes growth and proliferative responses in NIH 3T3 cells
(30). Thus, cell type differences as well as different
consequences of transient versus sustained Rac1 activation may also
account for the different observations seen in the two studies.
Finally, we have determined that the insert region is dispensable for
the ability of Rac1 to induce focus formation (Fig. 2), promote soft
agar growth (Fig. 4), enhance DNA synthesis (Fig. 5), increase
saturation density, and promote growth in low serum (data not shown).
These transformation assays, using sustained and transient expression
analyses in NIH 3T3 cells, were similar to those used by Wu et al.
(64) and Zong et al. (67). Consequently, a
comparison of our observations is more straightforward with the studies
on Cdc42 and RhoA than with the previous Rac1 studies and establishes
the distinct role the insert region plays in the actin-reorganizing and
growth-regulating functions of these Rho GTPases.
The involvement of the insert region of Rac1 in ROS production has been
derived mainly from in vitro biochemical analyses of the phagocytic
NADPH oxidase system (10, 13, 16, 41, 45), despite the
fact that other studies reached different conclusions (11, 31,
59). Nevertheless, a recent report demonstrated that truncation
of the insert region severely impaired the ability of transiently
expressed Rac1 to promote ROS generation in nonphagocytic COS-1 cells
(24). This mutant also lacked the ability to trigger NF-
B-mediated survival pathways in REF-52 cells (25),
which is consistent with previous observations that implicated ROS
production in mediating Rac1 activation of the NF-
B transcription
factor (4, 23). In contrast, we show here that NIH 3T3
fibroblasts stably expressing the activated Rac1 (61L) protein
stimulated ROS production and NF-
B activation that was not dependent
on an intact insert region. Interestingly, we have observed
that blocking NF-
B activation in Rac1(61L)-transformed NIH 3T3
cells did not inhibit ROS production but did impair
anchorage-independent growth (data not shown), indicating that
ROS-mediated activation of NF-
B contributes to Rac1 growth stimulation.
As discussed above, these differences may be due to the differences in
activating mutation, cell type, and/or temporal expression. Different
cell types possess varying mechanisms for regulating and coping with
ROS elevation, and alterations in those levels can trigger
growth-promoting or inhibitory signals depending on the origin of the
cell system (25, 26, 33). There is evidence that
ROS-dependent NF-
B activation is cell type specific
(4), and it would not be surprising if ROS thresholds
required to activate NF-
B are also cell type dependent and isoform
specific (7). The recent description of multiple
tissue-specific gp91 phox homologues such as Mox1 and Renox (15,
55) suggests that multiple genes code for distinct NADPH
oxidase-like systems. Consequently, these observations raise the
possibility that some NADPH oxidase systems particular to NIH 3T3 but
not REF-52 cells may not require the insert region of Rac1, while
others may require it. Further analyses characterizing the mechanisms
of Rac1-mediated ROS generation in fibroblasts will be required before
we can determine the basis for the observed differences.
One significant consequence of the insert region deletion was its
abrogation of the ability of Rac1 to promote membrane ruffling. In
contrast to a previous transient expression analysis in COS-1 cells
(24), we observed that transient or stable expression of
the insert region deletion mutant in NIH 3T3 cells reproducibly induced
the dissolution of actin stress fibers together with the appearance of
filopodium-like actin structures at the cell periphery. Differences in
the cytoskeletal phenotypes induced by Rac1 effector domain mutants
[for example, Rac1 (37A)] have been observed in different cell types
(50, 62), and it would not be surprising that COS-1 and
NIH 3T3 cells also exhibit similar variations. Finally, the observation
that the insert region was not involved in Cdc42-mediated actin changes
in NIH 3T3 cells (64) while the insert sequence was
essential for Rac1-mediated membrane ruffling in the same cell system
further emphasizes the distinct role the insert region plays in
different Rho GTPases.
Several possible scenarios may explain our observations of the Rac1
(61L,
ins) actin reorganization activity. First, deletion of the
insert region may have impaired Rac1 interaction with an effector(s)
important for membrane ruffling regulation. Second, the deletion of the
insert region may have caused a dominant-negative phenotype for Rac1.
For example, it was shown that a dominant-negative mutant of one Rho
family protein may actually promote actin reorganization changes
caused by a different Rho family member (40).
Accordingly, the insert region deletion mutant may act as a
dominant-negative inhibitor of membrane ruffling, thereby shifting the
balance of activity of Rac1 relative to other Rho family members,
resulting in the induction of filopodium-like actin projections.
In addition to the impairment in membrane ruffling, the insert mutant
was also impaired in its ability to activate SRF. Several observations
suggest that there may be a connection between SRF activation and
cytoskeletal remodeling. Treisman and coworkers have shown that SRF
activation is responsive to the relative levels of monomeric G and
polymerized F actin (54). Similarly, a Rac1(37A) mutant
unable to activate SRF (62) was found to be aberrant in
membrane-ruffling activity while promoting filopodium formation in NIH
3T3 cells (50). This SRF inactivation paralleled
repression of membrane ruffling with a concomitant induction of
filopodium-like structures in our system using the Rac1(61L,
ins)
mutant. Whether this correlation holds true for other mutants of
Rac1 merits further investigation.
Interestingly, subtle point mutations in the insert region (124A, 127A,
and 130A), in contrast to its entire deletion, did not affect the
ability of Rac1(61L) to cause membrane ruffling (data not shown) and to
stimulate SRF activity in NIH 3T3 cells. One possible interpretation of
these results is that the insert deletion induced alterations distal to
the mutation site, which then resulted in the changes seen in SRF and
membrane ruffling. However, our recent nuclear magnetic resonance
analyses of the Rac1(
ins) mutant, when compared to the wild-type
Rac1 protein, revealed no major structural perturbations upon deletion
of the insert sequence (R. Thapar, A. E. Karnoub, and S. L. Campbell, unpublished data). This observation supports the model that
the insert is involved in direct interactions with an effector(s) controlling actin reorganization and/or SRF activation.
The fact that the insert region may serve a distinct role in different
Rho family GTPases is not unexpected considering that the insert region
is one of the sequences of greatest divergence among Rho family
proteins (60). This divergence extends beyond sequence
homology. First, the Rho insert region assumes different structural
conformations in different Rho family GTPases. The crystal structures
of Rac1 (20) and RhoA (22) showed that their
inserts each form two short
-helices followed by an extended loop.
However, the nuclear magnetic resonance solution structure of Cdc42
shows no evidence for one of the helices and the other lies in a region
of low electron density (12). Additionally, the insert of
Cdc42Hs is very flexible and lies in close proximity to residues 84 to
89 (12, 35), while the insert of Rac1 was shown to be
mostly solvent exposed (20).
Second, the insert region mediates differential interactions with
various partners. For instance, in Cdc42 the insert is important for
guanine nucleotide dissociation inhibitor-mediated GDP release (63) and forms a binding interface for IQGAP1
but not for PAK1 or WASP (34). Similarly, Missy et al.
showed that the insert of Rac1 but not of Cdc42 is involved in binding
phosphoinositide 3,4,5-triphosphate and phosphoinositide
4,5-biphosphate (38). Together these results suggest that
the Rho insert region, by (i) having different sequence and structural
features, (ii) mediating different biochemical interactions, and (iii)
assuming different biological functions, may act as a
specificity-determining regulatory unit conducting distinct effector
interactions in various Rho family GTPases.
In summary, our results do not implicate the insert region of Rac1 in
cellular transformation or superoxide production in NIH 3T3 cells.
Instead, we show that this region is crucial for Rac1 induction of
membrane ruffling and SRF activation. These data suggest that the Rho
insert region, unlike the core effector domain, does not serve a common
function in all Rho family GTPases. Future studies to investigate what
role the Rac1 insert region plays in effector recognition and whether
it interacts with unique effector targets will help to clarify the
importance of the insert region in Rac1 function.
 |
ACKNOWLEDGMENTS |
We thank Carol Martin and Que Lambert for cell preparations,
Toren Finkel and Zu Xi-Yu for advice on the ROS analyses, Peggy Farnham
for the E2F-1 reporter plasmid, and Misha Rand for manuscript and
figure preparation.
Our research was supported by grants from the National Institutes
of Health to C.J.D. (CA42978, CA55008, and CA63071) and S.L.C. (CA70308 and CA64569).
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Lineberger
Comprehensive Cancer Center, University of North Carolina at Chapel
Hill, Chapel Hill, NC 27599. Phone: (919) 966-5634. Fax: (919)
966-0162. E-mail: cjder{at}med.unc.edu.
 |
REFERENCES |
| 1.
|
Abo, A.,
E. Pick,
A. Hall,
N. Totty,
C. G. Teahan, and A. W. Segal.
1991.
Activation of the NADPH oxidase involves the small GTP-binding protein p21racl.
Nature
353:668-670[CrossRef][Medline].
|
| 2.
|
Albanese, C.,
J. Johnson,
G. Watanabe,
N. Eklund,
D. Vu,
A. Arnold, and R. G. Pestell.
1995.
Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions.
J. Biol. Chem.
270:23589-23597[Abstract/Free Full Text].
|
| 3.
|
Bishop, A. L., and A. Hall.
2000.
Rho GTPases and their effector proteins.
Biochem. J.
348:241-255.
|
| 4.
|
Bonizzi, G.,
J. Piette,
S. Schoonbroodt,
R. Greimers,
L. Havard,
M. P. Merville, and V. Bours.
1999.
Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity.
Mol. Cell. Biol.
19:1950-1960[Abstract/Free Full Text].
|
| 5.
|
Clark, G. J.,
A. D. Cox,
S. M. Graham, and C. J. Der.
1995.
Biological assays for Ras transformation.
Methods Enzymol.
255:395-412[Medline].
|
| 6.
|
Clarke, N.,
N. Arenzana,
T. Hai,
A. Minden, and R. Prywes.
1998.
Epidermal growth factor induction of the c-jun promoter by a Rac pathway.
Mol. Cell. Biol.
18:1065-1073[Abstract/Free Full Text].
|
| 7.
|
Cool, R. H.,
E. Merten,
C. Theiss, and H. Acker.
1998.
Rac1, but not Rac2, is involved in the regulation of the intracellular hydrogen peroxide level in HepG2 cells.
Biochem. J.
332:5-8.
|
| 8.
|
Coso, O. A.,
M. Chiariello,
J. C. Yu,
H. Teramoto,
P. Crespo,
N. Xu,
T. Miki, and J. S. Gutkind.
1995.
The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway.
Cell
81:1137-1146[CrossRef][Medline].
|
| 9.
|
del Peso, L.,
R. Hernández-Alcoceba,
N. Embade,
A. Carnero,
P. Esteve,
C. Paje, and J. C. Lacal.
1998.
Rho proteins induce metastatic properties in vivo.
Oncogene
15:3047-3057.
|
| 10.
|
Diekmann, D.,
A. Abo,
C. Johnston,
A. W. Segal, and A. Hall.
1994.
Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity.
Science
265:531-533[Abstract/Free Full Text].
|
| 11.
|
Diekmann, D.,
C. D. Nobes,
P. D. Burbelo,
A. Abo, and A. Hall.
1995.
Rac GTPase interacts with GAPs and target proteins through multiple effector sites.
EMBO J.
14:5338-5349[Medline].
|
| 12.
|
Feltham, J. L.,
V. Dotsch,
S. Raza,
D. Manor,
R. A. Cerione,
M. J. Sutcliffe,
G. Wagner, and R. E. Oswald.
1997.
Definition of the switch surface in the solution structure of Cdc42Hs.
Biochemistry
36:8755-8766[CrossRef][Medline].
|
| 13.
|
Freeman, J. L.,
A. Abo, and J. D. Lambeth.
1996.
Rac "insert region" is a novel effector region that is implicated in the activation of NADPH oxidase, but not PAK65.
J. Biol. Chem.
271:19794-19801[Abstract/Free Full Text].
|
| 14.
|
Fujisawa, J. L.,
P. Madaule,
T. Ishizaki,
G. Watanabe,
H. Bito,
Y. Saito,
A. Hall, and S. Narumiya.
1998.
Different regions of Rho determine Rho-selective binding of different classes of Rho target molecules.
J. Biol. Chem.
273:18943-18949[Abstract/Free Full Text].
|
| 15.
|
Geiszt, M.,
J. B. Kopp,
P. Varnai, and T. L. Leto.
2000.
Identification of renox, an NAD(P)H oxidase in kidney.
Proc. Natl. Acad. Sci. USA
97:8010-8014[Abstract/Free Full Text].
|
| 16.
|
Gili, J., and E. Pick.
1995.
"Peptide walking" is a novel method for mapping functional domains in proteins.
J. Biol. Chem.
270:29079-29082[Abstract/Free Full Text].
|
| 17.
|
Gjoerup, O.,
J. Lukas,
J. Bartek, and B. M. Willumsen.
1998.
Rac and Cdc42 are potent stimulators of E2F-dependent transcription capable of promoting retinoblastoma susceptibility gene product hyperphosphorylation.
J. Biol. Chem.
273:18812-18818[Abstract/Free Full Text].
|
| 18.
|
Hall, A.
1998.
Rho GTPases and the actin cytoskeleton.
Science
279:509-514[Abstract/Free Full Text].
|
| 19.
|
Hill, C. S.,
J. Wynne, and R. Treisman.
1995.
The Rho family GTPases RhoA, Rac1 and Cdc42Hs regulate transcriptional activation by SRF.
Cell
81:1159-1170[CrossRef][Medline].
|
| 20.
|
Hirshberg, M.,
R. W. Stockley,
G. Dodson, and M. R. Webb.
1997.
The crystal structure of human rac1, a member of the rho-family complexed with a GTP analogue.
Nat. Struct. Biol.
4:147-152[CrossRef][Medline].
|
| 21.
|
Hsiao, K.-M.,
S. L. McMahon, and P. J. Farnham.
1994.
Multiple DNA elements are required for the growth regulation of the mouse E2F1 promoter.
Genes Dev.
8:1526-1537[Abstract/Free Full Text].
|
| 22.
|
Ihara, K.,
S. Muraguchi,
M. Kato,
T. Shimizu,
M. Shirakawa,
S. Kuroda,
K. Kaibuchi, and T. Hakoshima.
1998.
Crystal structure of human RhoA in a dominantly active form complexed with a GTP analogue.
J. Biol. Chem.
273:9656-9666[Abstract/Free Full Text].
|
| 23.
|
Irani, K.,
Y. Xia,
J. L. Zweier,
S. J. Sollott,
C. J. Der,
E. R. Fearon,
M. Sundaresan,
T. Finkel, and P. J. Goldschmidt-Clermont.
1997.
Mitogenic signaling mediated by oxidants in Ras-transformed fibroblasts.
Science
275:1649-1652[Abstract/Free Full Text].
|
| 24.
|
Joneson, T., and D. Bar-Sagi.
1998.
A Rac1 effector site controlling mitogenesis through superoxide production.
J. Biol. Chem.
273:17991-17994[Abstract/Free Full Text].
|
| 25.
|
Joneson, T., and D. Bar-Sagi.
1999.
Suppression of Ras-induced apoptosis by the Rac GTPase.
Mol. Cell. Biol.
19:5892-5901[Abstract/Free Full Text].
|
| 26.
|
Kawasaki, T.,
K. Henmi,
E. Ono,
S. Hatakeyama,
M. Iwano,
H. Satoh, and K. Shimamoto.
1999.
The small GTP-binding protein rac is a regulator of cell death in plants.
Proc. Natl. Acad. Sci. USA
96:10922-10926[Abstract/Free Full Text].
|
| 27.
|
Keely, P. J.,
J. K. Westwick,
I. P. Whitehead,
C. J. Der, and L. V. Parise.
1997.
Cdc42 and Rac1 induce integrin-mediated cell motility and invasiveness through PI(3)K.
Nature
390:632-636[CrossRef][Medline].
|
| 28.
|
Kheradmand, F.,
E. Werner,
P. Tremble,
M. Symons, and Z. Werb.
1998.
Role of Rac1 and oxygen radicals in collagenase-1 expression induced by cell shape change.
Science
280:898-902[Abstract/Free Full Text].
|
| 29.
|
Khosravi-Far, R.,
P. A. Solski,
G. J. Clark,
M. S. Kinch, and C. J. Der.
1995.
Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation.
Mol. Cell. Biol.
15:6443-6453[Abstract].
|
| 30.
|
Khosravi-Far, R.,
M. A. White,
J. K. Westwick,
P. A. Solski,
M. Chrzanowska-Wodnicka,
L. Van Aelst,
M. H. Wigler, and C. J. Der.
1996.
Oncogenic Ras activation of Raf/MAP kinase-independent pathways is sufficient to cause tumorigenic transformation.
Mol. Cell. Biol.
16:3923-3933[Abstract].
|
| 31.
|
Kwong, C. H.,
A. G. Adams, and T. L. Leto.
1995.
Characterization of the effector-specifying domain of Ras involved in NADPH oxidase activation.
J. Biol. Chem.
270:19868-19872[Abstract/Free Full Text].
|
| 32.
|
Kwong, C. H.,
H. L. Malech,
D. Rotrosen, and T. L. Leto.
1993.
Regulation of the human neutrophil NADPH oxidase by rho-related G-proteins.
Biochemistry
32:5711-5717[CrossRef][Medline].
|
| 33.
|
Lee, A. C.,
B. E. Fenster,
H. Ito,
K. Takeda,
N. S. Bae,
T. Hirai,
Z. X. Yu,
V. J. Ferrans,
B. H. Howard, and T. Finkel.
1999.
Ras proteins induce senescence by altering the intracellular levels of reactive oxygen species.
J. Biol. Chem.
274:7936-7940[Abstract/Free Full Text].
|
| 34.
|
Li, R.,
B. Debreceni,
B. Jia,
Y. Gao,
G. Tigyi, and Y. Zheng.
1999.
Localization of the PAK1-, WASP-, and IQGAP1-specifying regions of Cdc42.
J. Biol. Chem.
274:29648-29654[Abstract/Free Full Text].
|
| 35.
|
Loh, A. P.,
W. Guo,
L. K. Nicholson, and R. E. Oswald.
1999.
Backbone dynamics of inactive, active, and effector-bound Cdc42Hs from measurements of (15)N relaxation parameters at multiple field strengths.
Biochemistry
38:12547-12557[CrossRef][Medline].
|
| 36.
|
Michiels, F.,
G. G. Habets,
J. C. Stam,
R. A. van der Kammen, and J. G. Collard.
1995.
A role for Rac in Tiam1-induced membrane ruffling and invasion.
Nature
375:338-340[CrossRef][Medline].
|
| 37.
|
Minden, A.,
A. Lin,
F.-X. Claret,
A. Abo, and M. Karin.
1995.
Selective activation of the JNK signaling cascade and c-Jun transcriptional activity by the small GTPases Rac and Cdc42Hs.
Cell
81:1147-1157[CrossRef][Medline].
|
| 38.
|
Missy, K.,
P. Van,
V. P. Raynal,
C. Viala,
G. Mauco,
M. Plantavid,
H. Chap, and B. Payrastre.
1998.
Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation.
J. Biol. Chem.
273:30279-30286[Abstract/Free Full Text].
|
| 39.
|
Montaner, S.,
R. Perona,
L. Saniger, and J. C. Lacal.
1998.
Multiple signalling pathways lead to the activation of the nuclear factor kappaB by the Rho family of GTPases.
J. Biol. Chem.
273:12779-12785[Abstract/Free Full Text].
|
| 40.
|
Moorman, J. P.,
D. Luu,
J. Wickham,
D. A. Bobak, and C. S. Hahn.
1999.
A balance of signaling by Rho family small GTPases RhoA, Rac1 and Cdc42 coordinates cytoskeletal morphology but not cell survival.
Oncogene
18:47-57[CrossRef][Medline].
|
| 41.
|
Nisimoto, Y.,
J. L. R. Freeman,
S. A. Motalebi,
M. Hirshberg, and J. D. Lambeth.
1997.
Rac binding to p67phox.
J. Biol. Chem.
272:18834-18841[Abstract/Free Full Text].
|
| 42.
|
Ohba, M.,
M. Shibanuma,
T. Kuroki, and K. Nose.
1994.
Production of hydrogen peroxide by transforming growth factor-beta 1 and its involvement in induction of egr-1 in mouse osteoblastic cells.
J. Cell Biol.
126:1079-1088[Abstract/Free Full Text].
|
| 43.
|
Olson, M. F.,
A. Ashworth, and A. Hall.
1995.
An essential role for Rho, Rac and Cdc42 GTPases in cell cycle progression through G1.
Science
269:1270-1272[Abstract/Free Full Text].
|
| 44.
|
Perona, R.,
S. Montaner,
L. Saniger,
I. Sánchez-Pérez,
R. Bravo, and J. C. Lacal.
1997.
Activation of the nuclear factor-KB by Rho, CDC42, and Rac-1 proteins.
Genes Dev.
11:463-475[Abstract/Free Full Text].
|
| 45.
|
Prigmore, E.,
S. Ahmed,
A. Best,
R. Kozma,
E. Manser,
A. W. Segal, and L. Lim.
1995.
A 68-kDa kinase and NADPH oxidase component p67phox are targets for Cdc42Hs and Rac1 in neutrophils.
J. Biol. Chem.
270:10717-10722[Abstract/Free Full Text].
|
| 46.
|
Qiu, R.-G.,
J. Chen,
D. Kirn,
F. McCormick, and M. Symons.
1995.
An essential role for Rac in Ras transformation.
Nature
374:457-459[CrossRef][Medline].
|
| 47.
|
Qiu, R.-G.,
A. Abo, and M. G. Steven.
2000.
A human homolog of the C. elegans polarity determinant Par-6 links Rac and Cdc42 to PKCzeta signaling and cell transformation.
Curr. Biol.
10:697-707[CrossRef][Medline].
|
| 48.
|
Ridley, A. J.,
H. F. Paterson,
C. L. Johnston,
D. Diekmann, and A. Hall.
1992.
The small GTP-binding protein rac regulates growth factor-induced membrane ruffling.
Cell
70:401-410[CrossRef][Medline].
|
| 49.
|
Sahai, E.,
A. S. Alberts, and R. Treisman.
1998.
RhoA effector mutants reveal distinct effector pathways for cytoskeletal reorganization, SRF activation and transformation.
EMBO J.
17:1350-1361[CrossRef][Medline].
|
| 50.
|
Schwartz, M. A.,
J. E. Meredith, and W. B. Kiosses.
1998.
An activated Rac mutant functions as a dominant negative for membrane ruffling.
Oncogene
17:625-629[CrossRef][Medline].
|
| 51.
|
Self, A. J.,
H. F. Paterson, and A. Hall.
1993.
Different structural organization of Ras and Rho effector domains.
Oncogene
8:655-661[Medline].
|
| 52.
|
Serrano, M.,
A. W. Lin,
M. E. McCurrach,
D. Beach, and S. W. Lowe.
1997.
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.
Cell
88:593-602[CrossRef][Medline].
|
| 53.
|
Shin, E. A.,
K. H. Kim,
S. I. Han,
K. S. Ha,
J. H. Kim,
K. I. Kang,
H. D. Kim, and H. S. Kang.
1999.
Arachidonic acid induces the activation of the stress-activated protein kinase, membrane ruffling and H2O2 production via a small GTPase Rac1.
FEBS Lett.
452:355-359[CrossRef][Medline].
|
| 54.
|
Sotiropoulos, A.,
D. Gineitis,
J. Copeland, and R Treisman.
1999.
Signal-regulated activation of serum response factor is mediated by changes in actin dynamics.
Cell
98:159-169[CrossRef][Medline].
|
| 55.
|
Suh, Y. A.,
R. S. Arnold,
B. Lassegue,
J. Shi,
X. Xu,
D. Sorescu,
A. B. Chung,
K. K. Griendling, and J. D. Lambeth.
1999.
Cell transformation by the superoxide-generating oxidase Mox1.
Nature
401:79-82[CrossRef][Medline].
|
| 56.
|
Sulciner, D. J.,
K. Irani,
Z.-X. Yu,
V. J. Ferrans,
P. Goldschmidt-Clermont, and T. Finkel.
1996.
Rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF- B activation.
Mol. Cell. Biol.
16:7115-7121[Abstract].
|
| 57.
|
Sundaresan, M.,
Z. X. Yu,
V. J. Ferrans,
K. Irani, and T. Finkel.
1995.
Requirement for generation of H2O2 for platelet-derived growth factor signal transduction.
Science
270:296-299[Abstract/Free Full Text].
|
| 58.
|
Sundaresan, M.,
Z. X. Yu,
V. J. Ferrans,
D. J. Sulciner,
J. S. Gutkind,
K. Irani,
P. J. Goldschmidt-Clermont, and T. Finkel.
1996.
Regulation of reactive-oxygen-species generation in fibroblasts by Rac1.
Biochem. J.
318:379-382.
|
| 59.
|
Toporik, A.,
Y. Gorzalczany,
M. Hirshberg,
E. Pick, and O. Lotan.
1998.
Mutational analysis of novel effector domains in Rac1 involved in the activation of nicotinamide adenine dinucleotide phosphate (reduced) oxidase.
Biochemistry
37:7147-7156[CrossRef][Medline].
|
| 60.
|
Valencia, A.,
P. Chardin,
A. Wittinghofer, and C. Sander.
1991.
The ras protein family: evolutionary tree and role of conserved amino acids.
Biochemistry
30:4637-4648[CrossRef][Medline].
|
| 61.
|
Van Aelst, L., and C. D'Souza-Schorey.
1997.
Rho GTPases and signaling networks.
Genes Dev.
11:2295-2322[Free Full Text].
|
| 62.
|
Westwick, J. K.,
Q. T. Lambert,
G. J. Clark,
M. Symons,
L. Van Aelst,
R. G. Pestell, and C. J. Der.
1997.
Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.
Mol. Cell. Biol.
17:1324-1335[Abstract].
|
| 63.
|
Wu, J. W.,
D. A. Leonard,
A. Cerione, and D. Manor.
1997.
Interaction between Cdc42Hs and RhoGDI is mediated through the Rho insert region.
J. Biol. Chem.
272:26153-26158[Abstract/Free Full Text].
|
| 64.
|
Wu, J. W.,
R. Lin,
A. Cerione, and D. Manor.
1998.
Transformation activity of Cdc42 requires a region unique to Rho-related proteins.
J. Biol. Chem.
273:16655-16658[Abstract/Free Full Text].
|
| 65.
|
Zohar, M.,
H. Teramoto,
B. Z. Katz,
K. M. Yamada, and J. S. Gutkind.
1998.
Effector domain mutants of Rho dissociate cytoskeletal changes from nuclear signaling and cellular transformation.
Oncogene
17:991-998[CrossRef][Medline].
|
| 66.
|
Zohn, I. M.,
S. L. Campbell,
R. Khosravi-Far,
K. L. Rossman, and C. J. Der.
1998.
Rho family proteins and Ras transformation: the RHOad less traveled gets congested.
Oncogene
17:1415-1438[CrossRef][Medline].
|
| 67.
|
Zong, H.,
N. Raman,
L. A. Mickelson-Young,
S. J. Atkinson, and L. A. Quilliam.
1999.
Loop 6 of RhoA confers specificity for effector binding, stress fiber formation, and cellular transformation.
J. Biol. Chem.
274:4551-4560[Abstract/Free Full Text].
|
Molecular and Cellular Biology, April 2001, p. 2847-2857, Vol. 21, No. 8
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.8.2847-2857.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Lammers, M., Meyer, S., Kuhlmann, D., Wittinghofer, A.
(2008). Specificity of Interactions between mDia Isoforms and Rho Proteins. J. Biol. Chem.
283: 35236-35246
[Abstract]
[Full Text]
-
Owen, D., Campbell, L. J., Littlefield, K., Evetts, K. A., Li, Z., Sacks, D. B., Lowe, P. N., Mott, H. R.
(2008). The IQGAP1-Rac1 and IQGAP1-Cdc42 Interactions: INTERFACES DIFFER BETWEEN THE COMPLEXES. J. Biol. Chem.
283: 1692-1704
[Abstract]
[Full Text]
-
Keller, P. J., Gable, C. M., Wing, M. R., Cox, A. D.
(2005). Rac3-Mediated Transformation Requires Multiple Effector Pathways. Cancer Res.
65: 9883-9890
[Abstract]
[Full Text]
-
Pop, M., Aktories, K., Schmidt, G.
(2004). Isotype-specific Degradation of Rac Activated by the Cytotoxic Necrotizing Factor 1. J. Biol. Chem.
279: 35840-35848
[Abstract]
[Full Text]
-
Werner, E.
(2004). GTPases and reactive oxygen species: switches for killing and signaling. J. Cell Sci.
117: 143-153
[Abstract]
[Full Text]
-
Joyce, P. L., Cox, A. D.
(2003). Rac1 and Rac3 Are Targets for Geranylgeranyltransferase I Inhibitor-Mediated Inhibition of Signaling, Transformation, and Membrane Ruffling. Cancer Res.
63: 7959-7967
[Abstract]
[Full Text]
-
Vilhardt, F., Plastre, O., Sawada, M., Suzuki, K., Wiznerowicz, M., Kiyokawa, E., Trono, D., Krause, K.-H.
(2002). The HIV-1 Nef Protein and Phagocyte NADPH Oxidase Activation. J. Biol. Chem.
277: 42136-42143
[Abstract]
[Full Text]
-
Bokoch, G. M., Diebold, B. A.
(2002). Current molecular models for NADPH oxidase regulation by Rac GTPase. Blood
100: 2692-2695
[Abstract]
[Full Text]
-
Sachdev, P., Zeng, L., Wang, L. H.
(2002). Distinct Role of Phosphatidylinositol 3-Kinase and Rho Family GTPases in Vav3-induced Cell Transformation, Cell Motility, and Morphological Changes. J. Biol. Chem.
277: 17638-17648
[Abstract]
[Full Text]
-
Zong, H., Kaibuchi, K., Quilliam, L. A.
(2001). The Insert Region of RhoA Is Essential for Rho Kinase Activation and Cellular Transformation. Mol. Cell. Biol.
21: 5287-5298
[Abstract]
[Full Text]